Pharmaceutical prerequisites for a multi-target therapy.
about
Chamomile: A herbal medicine of the past with a bright future (Review)Pharmacognostical Analysis and Protective Effect of Standardized Extract and Rizonic Acid from Erythrina velutina against 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disordersDevelopment and validation of a high-performance liquid chromatography method for quantification of egonol and homoegonol in Styrax species.Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family.Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon CancerClinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial.Anti-inflammatory Effects of Herbal Preparations STW5 and STW5-II in Cytokine-Challenged Normal Human Colon CellsLemon balm extract causes potent antihyperglycemic and antihyperlipidemic effects in insulin-resistant obese mice.Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation.Investigation of STW 5 (Iberogast®) preventive effects in experimental sepsis.A "novel" protocol for the analysis of hydroxycinnamic acids in leaf tissue of chicory (Cichorium intybus L., Asteraceae).
P2860
Q24632610-4BFF1939-5431-4D56-98BC-34A9E3AE2FD8Q31143508-366F47AA-955E-4F91-9593-376462D74787Q33617439-C9D0A138-D8B4-4842-B1A0-6B672D13EE1FQ34054770-3CC32167-8515-45AD-822F-0F98EC1D2937Q35050607-013027C2-71C2-49EC-806C-D5D0D75216E2Q35981239-AE6FD18C-FEFE-46EE-86F6-C44ABD6AE813Q36800893-C0D4A76C-47EC-4522-A182-9F91C16945B4Q38731835-E3EA784A-83A1-406E-BDAD-05FC91F7275DQ42239435-94993C79-A8E9-41D8-8043-75196A35F88FQ42413341-4AA60E93-B325-4F6D-A124-D7F09BBE5E49Q45823204-4BBBF306-E569-44F7-96BA-17D6D1FAAA33Q55127977-508FAB80-0202-4777-8FCE-31EDD4B8B316
P2860
Pharmaceutical prerequisites for a multi-target therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmaceutical prerequisites for a multi-target therapy.
@ast
Pharmaceutical prerequisites for a multi-target therapy.
@en
type
label
Pharmaceutical prerequisites for a multi-target therapy.
@ast
Pharmaceutical prerequisites for a multi-target therapy.
@en
prefLabel
Pharmaceutical prerequisites for a multi-target therapy.
@ast
Pharmaceutical prerequisites for a multi-target therapy.
@en
P1433
P1476
Pharmaceutical prerequisites for a multi-target therapy.
@en
P2093
P356
10.1016/J.PHYMED.2006.03.016
P478
13 Suppl 5
P577
2006-07-20T00:00:00Z